Private Equity’s Tighter Grip; ApoB Inhibitors vs Liver? Promising New RDN System

Nearly half of all cardiology private practices were under private equity as of 2023, and there was a slight decrease in the proportion of groups owned by hospital systems, according to a MedAxiom compensation report.

Constant sitting may not be good for cardiovascular health, but standing is also linked to circulatory issues, such as varicose veins and deep vein thrombosis. (International Journal of Epidemiology)

Hearing and vision impairments were associated with cardiovascular disease in a Chinese longitudinal cohort. (Journal of the American Heart Association)

Can the inhibition of apolipoprotein B be linked to an increased risk of liver-related adverse events? (Journal of the American College of Cardiology)

Women die more often after high-risk surgery not because they have more complications — but because of more frequent failure to rescue. (JAMA Surgery)

Black patients had a 22% excess risk of mortality after coronary bypass surgery compared with white peers in recent years, according to national data highlighted by the American Society of Anesthesiologists.

Boston Scientific announced FDA approval of their Farawave NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance of their Faraview software to help visualize cardiac ablation procedures with the Farapulse Pulsed Field Ablation System.

The Gentuity HF-OCT Imaging System also received FDA 510(k) clearance for intravascular imaging before and after percutaneous coronary intervention (PCI).

For patients with an indication for oral anticoagulation undergoing PCI, use of the Cobra polyzene F stent plus 14 days of dual antiplatelet therapy fell short in thromboembolic protection, a randomized trial showed. (Circulation: Cardiovascular Interventions)

A meta-analysis favored tenecteplase (TNKase) over alteplase (Activase) for functional outcomes after an ischemic stroke. (Neurology)

A low-dose triple polypill containing telmisartan, amlodipine, and indapamide led to clinically meaningful improvements in blood pressure (BP) reduction compared with dual combinations of these drugs in people with hypertension. (The Lancet)

The Netrod six-electrode radiofrequency renal denervation (RDN) system reduced BP among Chinese patients with uncontrolled primary hypertension, a sham-controlled trial showed. (European Heart Journal)

Real-world data suggest good results with contemporary left ventricular assist devices in younger people not usually considered to be candidates for this therapy before heart transplantation. (Annals of Thoracic Surgery)

After cardiac transplant, sympathetic reinnervation of the sinus node typically occurs in the first 18 months and is tied to improved long-term survival. (Journal of Heart and Lung Transplantation)

The mode of action of SGLT2 inhibitors appeared to be related to fatty acid and amino acid metabolism, results from two randomized trials showed. (Circulation: Heart Failure)

Please enable JavaScript to view the comments powered by Disqus.